Triethylamine → (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(methoxyamino)-2-(phenylethynyl)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

HRID 895102

Reaktionsgleichung

Reaktionsgleichung von HRID 895102
[C:1]1([C:7]#[CH:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[OH:9][CH2:10][C@H:11]1[O:15][C@@H:14]([N:16]2[CH:24]=[N:23][C:22]3[C:17]2=[N:18][C:19](I)=[N:20][C:21]=3[NH:25][O:26][CH3:27])[C@H:13]([OH:29])[C@@H:12]1[OH:30].C(N(CC)CC)C>CN(C)C=O.[Cu]I.Cl[Pd](Cl)([P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1)[P](C1C=CC=CC=1)(C1C=CC=CC=1)C1C=CC=CC=1>[OH:9][CH2:10][C@H:11]1[O:15][C@@H:14]([N:16]2[CH:24]=[N:23][C:22]3[C:17]2=[N:18][C:19]([C:8]#[C:7][C:1]2[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=2)=[N:20][C:21]=3[NH:25][O:26][CH3:27])[C@H:13]([OH:29])[C@@H:12]1[OH:30]

Komponenten

7

Edukt 3

HCID 8471TriethylamineHCID 10821PhenylacetyleneHCID 16115751(4S,2R,3R,5R)-5-(hydroxymethyl)-2-[2-iodo-6-(methoxyamino)purin-9-yl]oxolane-3,4-diol

Produkt 1

HCID 10046345(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(methoxyamino)-2-(phenylethynyl)-9H-purin-9-yl)tetrahydrofuran-3,4-diol

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)KatalysatorHCID 178418476HCID 178418476, VerbindungKatalysatorHCID 6228DimethylformamideLösungsmittel

Versuchsvorschrift

CuI (0.35 mg, 0.002 mmol) and phenylacetylene (2.1 mmol) were added to a solution of (4S,2R,3R,5R)-5-(hydroxymethyl)-2-[2-iodo-6-(methoxyamino)purin-9-yl]oxolane-3,4-diol (0.35 mmol), a compound of formula (5), in dry N,N-dimethylformamide (6 mL) and triethylamine (1.4 mL) under an atmosphere of nitrogen in the presence of bis(triphenylphosphine)palladium dichloride (5 mg, 0.007 mmol). The reaction mixture was stirred at room temperature for 5 hours. After evaporation under reduced pressure the residual oil was purified by silica gel column chromatography, eluting with chloroform/methanol 90/10. After evaporation in vacuo, the residual oil was purified by silica gel column chromatography, eluting with the suitable mixture of solvents, to provide (4S,2R,3R,5R)-5-(hydroxymethyl)-2-[6-(methoxyamino)-2-(2-phenylethynyl)purin-9-yl]oxolane-3,4-diol, a compound of Formula I (mp 175-177° C.).

Aufarbeitung

  1. customAfter evaporation under reduced pressure the residual oil
  2. customwas purified by silica gel column chromatography
  3. washeluting with chloroform/methanol 90/10
  4. customAfter evaporation in vacuo
  5. customthe residual oil was purified by silica gel column chromatography
  6. washeluting with the suitable mixture of solvents

Quellen und Nachweise

ORD-Eintrag
ord-716de53f06884d07ad44a733f68eff90
Quelldatensatz
uspto-grants-2005_07
Patentnummer
US06914053B2

Verknüpfte Notizen

Wird geladen…